Close
  Indian J Med Microbiol
 

Figure 4: (a) Effect of baicalin on lipopolysaccharide-stimulated RAW264.7 cells. (b) Effect of baicalin on 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis rats. (c) The effect of baicalin on catalase activity; (d) the effect of baicalin on glutathione peroxidase activity. &P < 0.05 and &&P < 0.01, lipopolysaccharide versus BSA control; *P < 0.05 and **P < 0.01, mesalazine versus lipopolysaccharide group; #P < 0.05 and ##P < 0.01, baicalin versus lipopolysaccharide group. Data from individual experiments are presented as means ± standard deviation (n = 3, in vitro; n = 6, in vivo)

Figure 4: (a) Effect of baicalin on lipopolysaccharide-stimulated RAW264.7 cells. (b) Effect of baicalin on 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis rats. (c) The effect of baicalin on catalase activity; (d) the effect of baicalin on glutathione peroxidase activity. &<i>P</i> < 0.05 and &&<i>P</i> < 0.01, lipopolysaccharide versus BSA control; *<i>P</i> < 0.05 and **<i>P</i> < 0.01, mesalazine versus lipopolysaccharide group; #<i>P</i> < 0.05 and ##<i>P</i> < 0.01, baicalin versus lipopolysaccharide group. Data from individual experiments are presented as means ± standard deviation (<i>n</i> = 3, <i>in vitro</i>; <i>n</i> = 6, <i>in vivo</i>)